J. Finberg

发表

Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug

M. Briley, C. Moret, M. Charvéron, 1985, Neuropharmacology.

Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules

H. Haick, M. Humbert, O. Nativ, 2016, ACS nano.

Detection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors.

H. Haick, U. Tisch, R. Ionescu, 2012, ACS chemical neuroscience.

Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson’s disease

J. Finberg, 2018, Journal of Neural Transmission.

TYRAMINE ANTAGONISTIC PROPERTIES OF AGN 1135, AN IRREVERSIBLE INHIBITOR OF MONOAMINE OXIDASE TYPE B

M. Youdim, J. Finberg, M. Tenne, 1981, British journal of pharmacology.

Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-B.

R. Duvoisin, M. Youdim, J. Finberg, 1985, European journal of pharmacology.

Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat

J. Finberg, M. Youdim, 1985, British journal of pharmacology.

Pharmacology and neuroprotective properties of rasagiline.

M. Youdim, J. Finberg, M. Youdim, 1996, Journal of neural transmission. Supplementum.

Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey.

D. Goldstein, I. Kopin, J. Finberg, 1998, Journal of neural transmission. Supplementum.

Pharmacology of rasagiline (N-propargyl-1R-aminoindan).

M. Youdim, J. Finberg, M. Youdim, 1999, Advances in neurology.

Distinguishing idiopathic Parkinson's disease from other parkinsonian syndromes by breath test.

H. Haick, J. Finberg, M. Nakhleh, 2015, Parkinsonism & related disorders.

Selective inhibitors of monoamine oxidase type B and the "cheese effect".

J. Finberg, K. Gillman, 2011, International review of neurobiology.

Inhibition of nerve stimulation‐induced vasodilatation in corpora cavernosa of the pithed rat by blockade of nitric oxide synthase

J. Finberg, Y. Vardi, S. Levy, 1993, British journal of pharmacology.

Inhibitory effect of 5‐hydroxytryptamine on penile erectile function in the rat

J. Finberg, Y. Vardi, J.P.M. Finberg, 1990, British journal of pharmacology.

The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons

D. Ben-shachar, M. Youdim, J. Finberg, 1991, Journal of neurochemistry.

Oxidative Stress in Parkinson's Disease

J. Finberg, Y. Aluf, J. Vaya, 2011 .

Ultrastructural and cytochemical changes in the heart of iron-deficient rats.

R. Coleman, M. Youdim, J. Finberg, 1994, Biochemical pharmacology.

Selective Alteration in Blood‐Brain Barrier and Insulin Transport in Iron‐Deficient Rats

D. Ben-shachar, S. Yehuda, J. Finberg, 1988, Journal of neurochemistry.

Effect of Iron Chelators on Dopamine D2 Receptors

D. Ben-shachar, J. Finberg, M. Youdim, 1985, Journal of neurochemistry.

Contributions from Peripheral Autonomic Pharmacology to an Understanding of Antidepressant Drug Action

I. Kopin, J. Finberg, D. Hovevy-Sion, 1988 .

Alterations in striatal oxidative stress level produced by pharmacological manipulation of dopamine as shown by a novel synthetic marker molecule

J. Finberg, Y. Aluf, J. Vaya, 2011, Neuropharmacology.

Monoamine oxidase type B inhibitors in the treatment of Parkinson's disease.

M. Youdim, J. Finberg, J. Wajsbort, 1984, Progress in medicinal chemistry.

Effect of low‐dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine‐induced dopamine release in vivo

J. Finberg, R. Simantov, I. Lamensdorf, 1999, British journal of pharmacology.

Neurochemical Evidence for Agmatine Modulation of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Neurotoxicity

J. Rabey, J. Finberg, G. Gilad, 2005, Neurochemical Research.

Effect of Long‐Term Treatment with Selective Monoamine Oxidase A and B Inhibitors on Dopamine Release from Rat Striatum In Vivo

J. Finberg, M. Youdim, I. Lamensdorf, 1996, Journal of neurochemistry.

New directions in monoamine oxidase A and B selective inhibitors and substrates.

M. Youdim, J. Finberg, 1991, Biochemical pharmacology.

Monoamine Oxidase Type B Inhibitors in Human and Animal Parkinsonism

P. Riederer, M. Youdim, J. Finberg, 1986 .

CARDIOVASCULAR RESPONSIVENESS TO VASOACTIVE AGENTS IN RATS WITH OBSTRUCTIVE JAUNDICE

J. Finberg, O. Better, R. Seidman, 1982, Clinical and experimental pharmacology & physiology.

Presence of a non-peptide morphine-like compound in human CSF and urine

J. Finberg, S. Spector, J. Shorr, 1979 .

Blunted pressor response to angiotensin and sympathomimetic amines in bile-duct ligated dogs.

J. Finberg, O. Better, H. A. Syrop, 1981, Clinical science.

Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours

J. Finberg, M. Youdim, 2002, Neuropharmacology.

Bile salts, hypotension and obstructive jaundice.

J. Finberg, A. Bomzon, D. Tovbin, 1984, Clinical science.

Morphine Increases Myocardial Infarction Size in Rats

W. Markiewicz, J. Finberg, C. Lichtig, 1982, Anesthesia and analgesia.

Exposure to static magnetic field facilitates selective attention and neuroplasticity in rats

J. Finberg, A. Avital, S. Zubedat, 2022, Brain Research Bulletin.

Attenuation of methamphetamine induced dopaminergic neurotoxicity by flupirtine: microdialysis study on dopamine release and free radical generation

J. Finberg, M. Youdim, I. Lamensdorf, 2003, Journal of Neural Transmission.

Effects of gliosis on dopamine metabolism in rat striatum

E. Oldfield, J. Finberg, K. Bankiewicz, 1994, Brain Research.

Reduced peripheral presynaptic adrenoceptor sensitivity following chronic antidepressant treatment in rats

J. Finberg, A. Tal, 1985, British journal of pharmacology.

Effect of the Tricyclic Antidepressant Desipramine on β‐Adrenergic Receptors in Cultured Rat Glioma C6 Cells

P. Fishman, J. Finberg, 1987, Journal of neurochemistry.

RELATIONSHIP BETWEEN TYRAMINE POTENTIATION AND SELECTIVE INHIBITION OF MONOAMINE OXIDASE TYPES A AND B IN THE RAT VAS DEFERENS

J. Finberg, M. Tenne, J.P.M. FINBERG, 1982, British journal of pharmacology.

Chronic inhibition of monoamine oxidase reduces noradrenaline release in rat vas deferens and anococcygeus muscle

J. Finberg, D. Hovevey-Sion, 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.

Rasagiline enhances l-DOPA-induced contralateral turning in the unilateral 6-hydroxydopamine-lesioned guinea-pig

J. Finberg, A. Gross, D. Moses, 2004, Neuropharmacology.

Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats.

J. Finberg, G. Eisenhofer, 1994, The Journal of pharmacology and experimental therapeutics.

Jaundice, the circulation and the kidney.

J. Finberg, R. Beyar, J. Green, 1984, Nephron.

Mechanism of the antihypertensive action of clonidine on the pressor response to physostigmine.

J. Buccafusco, J. Finberg, S. Spector, 1980, The Journal of pharmacology and experimental therapeutics.

Monoamine oxidase B inhibition and the "cheese effect".

M. Youdim, J. Finberg, 1987, Journal of neural transmission. Supplementum.

Deamination of Aliphatic Amines by Monoamine Oxidase A and B Studied Using a Bioluminescence Technique

M. Youdim, J. Finberg, S. Ulitzur, 1985, Journal of neurochemistry.

Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea‐pig

J. Finberg, J P Finberg, T Ilani, 2000, British journal of pharmacology.

Reduced striatal tyrosine hydroxylase activity is not accompanied by change in responsiveness of dopaminergic receptors following chronic treatment with deprenyl

J. Finberg, I. Lamensdorf, J. P. M. Finberg, 1997, Neuropharmacology.

Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology

J. Rabey, J. Finberg, 2016, Front. Pharmacol..

Behavioural hyperactivity in rats treated with selective monoamine oxidase inhibitors and LM 5008, a selective 5‐hydroxytryptamine uptake blocker

J. Finberg, M. Youdim, R. Ashkenazi, 1983, British journal of pharmacology.

Chronic clonidine treatment produces desensitisation of post- but not presynaptic alpha 2-adrenoceptors.

I. Kopin, J. Finberg, 1987, European journal of pharmacology.

Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release.

J. Finberg, 2014, Pharmacology & therapeutics.

Copper pathology in vulnerable brain regions in Parkinson's disease

R. Ortega, K. Double, G. Halliday, 2014, Neurobiology of Aging.

Implications of MAO-A and MAO-B inhibition for antidepressant therapy.

M. Youdim, J. Finberg, 1983, Modern problems of pharmacopsychiatry.

Chronic clorgyline treatment enhances release of norepinephrine following sympathetic stimulation in the rat

I. Kopin, J. Finberg, 1986, Naunyn-Schmiedeberg's Archives of Pharmacology.

DEVELOPMENT OF A SPECIFIC RADIOIMMUNOASSAY FOR ACETYLCHOLINE

J. Finberg, S. Spector, G. Semenuk, 1978, Journal of neurochemistry.

Antidepressant drugs and down-regulation of presynaptic receptors.

J. Finberg, 1987, Biochemical pharmacology.

Chronic inhibition of monoamine oxidase type A increases noradrenaline release in rat frontal cortex

D. Goldstein, K. Pacak, I. Kopin, 1993, Naunyn-Schmiedeberg's Archives of Pharmacology.

Regional brain acetylcholine kinetics: effects of reserpine.

J. Buccafusco, J. Finberg, S. Spector, 1979, Life sciences.

Static Magnetic Field Exposure In Vivo Enhances the Generation of New Doublecortin-expressing Cells in the Sub-ventricular Zone and Neocortex of Adult Rats

J. Finberg, L. Schächter, Y. Loboda, 2019, Neuroscience.

Possible role for endothelins in penile erection.

J. Finberg, A. Hoffman, Y. Vardi, 1996, European journal of pharmacology.

Renin-angiotensin system in dogs following chronic bile-duct ligation. Relation to vascular reactivity.

L. Kahana, J. Finberg, Y. Naveh, 1988, Journal of hepatology.

Metabolic clearance rate of cortisol and aldosterone during controlled hyperthermia in man [proceedings].

J. Finberg, K. Collins, J. Few, 1977, The Journal of physiology.

The effect of angiotensin, noradrenaline and vasopressin on blood flow distribution in the rat kidney

J. Finberg, W. Peart, 1972, The Journal of physiology.

Intrarenal blood flow distribution in the rat, and the effect of angiotensin, noradrenaline and vasopressin.

J. Finberg, W. Peart, 1970, The Journal of physiology.

Analysis of volatile organic compounds in rats with dopaminergic lesion: Possible application for early detection of Parkinson’s disease

H. Haick, U. Tisch, Y. Lavner, 2014, Neurochemistry International.

Sensor Array for Detection of Early Stage Parkinson's Disease before Medication.

H. Haick, Y. Broza, J. Finberg, 2018, ACS chemical neuroscience.

Altered Volatile Organic Compound Profile in Transgenic Rats Bearing A53T Mutation of Human α-Synuclein: Comparison with Dopaminergic and Serotonergic Denervation.

H. Haick, J. Finberg, M. Nakhleh, 2017, ACS chemical neuroscience.

Binding of the endogenous nonpeptide morphine-like compound to opiate receptors.

J. Finberg, A. Blume, S. Spector, 1977, Proceedings of the National Academy of Sciences of the United States of America.

Inhibition of sympathetic nerve activity by acute administration of the tricyclic antidepressant desipramine.

J. Finberg, G. Di Bona, G. Lavian, 1991, European journal of pharmacology.

Abstracts of the 16th Annual Meeting of The Israel Society for Neuroscience Eilat, Israel, November 25–27, 2007

Yonina C. Eldar, Karl J. Friston, Leslie G. Ungerleider, 2008, Neural plasticity.

In vivo extracellular recording of sympathetic ganglion activity in a chronic animal model

D. Kopelman, R. Shofti, J. Finberg, 2003, Clinical Autonomic Research.

Effects of desipramine hydrochloride on peripheral sympathetic nerve activity.

M. Cohen, J. Finberg, M. Thames, 1990, The American journal of physiology.

Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson’s Disease with Neuroprotective Potential

J. Finberg, 2010, Rambam Maimonides medical journal.

Effects of forskolin in rat vas deferens--evidence for facilitatory beta-adrenoceptors.

M. Youdim, J. Finberg, A. Bomzon, 1983, European journal of pharmacology.

Peripheral vascular neuroeffector mechanisms in experimental cholestasis.

G. Jacob, J. Finberg, A. Bomzon, 1993, The American journal of physiology.

Nitric oxide and penile erection in streptozotocin-diabetic rats.

J. Finberg, Y. Vardi, G. Ari, 1999, Clinical science.

Effects of fibroblast transplantation into the internal pallidum on levodopa-induced dyskinesias in parkinsonian non-human primates

K. Mewes, C. Gutekunst, Arun Singh, 2015, Neuroscience Bulletin.

The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.

M. Youdim, J. Finberg, G. Lavian, 1993, Clinical neuropharmacology.

Pharmacology of reversible and selective inhibitors of monoamine oxidase type A

J. Finberg, 1995, Acta psychiatrica Scandinavica. Supplementum.

Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule

J. Finberg, Y. Aluf, J. Vaya, 2010, Free radical research.

TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease.

M. Youdim, J. Finberg, M. Weinstock, 2000, Journal of neural transmission. Supplementum.

Increased L‐DOPA‐derived dopamine following selective MAO‐A or ‐B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation

J. Finberg, M. Rabey, Y. Loboda, 2013, British journal of pharmacology.

Abstracts of the 16th Annual Meeting of The Israel Society for Neuroscience Eilat, Israel, November 25–27, 2007

Yonina C. Eldar, Karl J. Friston, Leslie G. Ungerleider, 2008, Neural plasticity.

Modification of L-DOPA pharmacological activity by MAO inhibitors

J. Finberg, O. Sader-Mazbar, 2007, Journal of Neural Transmission.

Early perceptual loss in depression

Yonina C. Eldar, Karl J. Friston, Charles R. Seger, 2007 .

The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's disease.

P Riederer, P. Riederer, M. Youdim, 1993, Advances in neurology.

Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway

J. Finberg, Y. Aluf, J. Vaya, 2013, Neuropharmacology.

Comparison of the effect of reversible and irreversible MAO inhibitors on renal nerve activity in the anesthetized rat.

M. Youdim, J. Finberg, G. Lavian, 1994, Journal of neural transmission. Supplementum.

Abstracts of the 15th Annual Meeting of the Israel Society for Neuroscience Eilat, Israel, December 3–5, 2006

Leslie G. Ungerleider, D. Amit, H. Seung, 2006, Neural Plasticity.

Influence of Selective Inhibition of Monoamine Oxidase A or B on Striatal Metabolism of l‐DOPA in Hemiparkinsonian Rats

D. Goldstein, J. Finberg, J. Wang, 1995, Journal of neurochemistry.

Pharmacological comparison between the actions of methamphetamine and 1-aminoindan stereoisomers on sympathetic nervous function in rat vas deferens.

J. Finberg, S. Glezer, 2003, European journal of pharmacology.

Effect of single and repeated administration of fluvoxamine on noradrenaline release in rat brain.

E. Klein, J. Finberg, A. Tabak, 1997, European journal of pharmacology.

Neuroprotective effect of weak static magnetic fields in primary neuronal cultures

J. Finberg, L. Schächter, Y. Loboda, 2014, Neuroscience.

Increased L‐DOPA‐derived dopamine following selective MAO‐A or ‐B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation

J. Finberg, M. Rabey, Y. Loboda, 2013, British journal of pharmacology.

Effects of fibroblast transplantation into the internal pallidum on levodopa-induced dyskinesias in parkinsonian non-human primates

K. Mewes, C. Gutekunst, Arun Singh, 2015, Neuroscience Bulletin.

Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L‐DOPA in the rat

M. Youdim, J. Finberg, O. Bar‐Am, 2006, British journal of pharmacology.

MAO type B inhibitors as adjunct to L-dopa therapy.

M. Youdim, J. Finberg, 1987, Advances in neurology.

Modification of alpha-2 presynaptic receptor activity and catecholamine release following chronic MAO inhibition.

J. Finberg, D. Hovevey-Sion, G. Lavian, 1990, Journal of neural transmission. Supplementum.

Modification of cerebral cortical noradrenaline release by chronic inhibition of MAO-A.

K. Pacak, I. Kopin, J. Finberg, 1994, Journal of neural transmission. Supplementum.